Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: relation to apolipoprotein-CIII gene polymorphism.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7909870.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The apolipoprotein CIII allele S2 is associated with hypertriglyceridaemia and myocardial infarction. 15 subjects with type 2 diabetes mellitus and the S2 allele had significantly greater systolic blood pressure than 48 without this allele (mean 142 [SD10]) vs 129 [14] mmHg), despite being on antihypertensives more frequently. S2 patients showed better glycaemic control (glycated haemoglobin [HbA1C] 8.4 [2.0] vs 9.9 [2.0]%). Stepwise multiple regression indicated S2 as an independent predictor of both blood pressure and HbA1C. These findings suggest mechanisms for relations between glucose and triglyceride metabolism and blood pressure.
Medical subject headings
- Apolipoproteins C
- Blood Pressure
- Coronary Disease
- Diabetes Mellitus, Type 2